Pfizer sales fall as company races toward COVID-19 vaccine
by from on (#56AC4)
Pfizer Inc. said it expects global demand for vaccinations against coronavirus illnesses to last at least several years, sharpening a long-term forecast for its experimental COVID-19 vaccine as the company moves forward with the final-stage of clinical testing.